Improving Global Outcomes in Metastatic Breast Cancer
Vaccines are only as effective as our ability to get them to people who need them most, no matter how remote or hard to reach
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Partnering in Hemophilia
Eliquis® Continues to Differentiate in NVAF
Advancing Sickle Cell Disease Awareness, Understanding & Diagnosis
Partnering to Help Protect Babies in the U.S.
Antibiotic-resistant pathogens are one of the largest threats to global health. Pfizer is proud to play a leading role in the fight against AMR
Driving Increased Colorectal Cancer Screening: Addressing a Substantial Unmet Need
BMS-Pfizer Alliance Working to Understand Gaps in Atrial Fibrillation (AFib) Detection and Diagnosis
Sparking Innovative Ideas to Deliver Vaccines to the Hardest-To-Reach "Last Mile"
Innovation in Chronic Pain Management
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families